Discover Orange Biomed’s journey and innovations in diabetes technology after the Diabetes Technology Meeting 2024, focusing on health equity and solutions.

Explore innovations in A1C testing at the Diabetes Technology Meeting 2024. Learn about Orange Biomed’s OBM rapid A1c and its impact on equitable diabetes care.

Stay Informed Ahead of the Next Diabetes Conference in 2025. The ADA’s (American Diabetes Association) 84th Scientific Sessions, held from June 21–24 in Orlando, Florida, showcased breakthrough research and discussions

Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And

5 Women Making Strides in Diabetes Care and Advocacy in 2023. Women’s History Month may be over, but that…

Seattle, WA, October 30, 2023—Orange Biomed—a healthcare startup with cutting-edge diabetes management technology—announced their attendance at major industry events: Diabetes Technology Meeting and MEDICA. Orange Biomed is a medical device

Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings The United States is home to many cultural and ethnic diversity. With this comes recognition of